Key Data Files for this Active Pharmaceutical Ingredient:

Drug Master Files, 21 CFR, and other industry portals Patent/Exclusivity data file Drug Approval Drug Safety Freedom of Information Federal Register pages Pharma Companies Pharmacopeial Information Preferred API Supplier (Clients Only)

FDA Approval Activities for this Drug… Innohep (tinzaparin sodium) Injection, Bristol-Myers Squibb Pharma Company NDA 20-484/S-002 2/5/02 4/17/02 Innohep (tinzaparin sodium) Injection, Dupont Pharmaceutical Company NDA 20-484 7/14/00 7/24/00 7/24/00 4/9/02 Innohep Indications: for the treatment of acute symptomatic deep vein thrombosis with or without pulmonary embolism when administered in conjunction with warfarin sodium.   For the latest approval information, locate this drug using this index.